Royalty Pharma RPRX Price / earnings
Price / earnings at other companies
Other financials
Where this comes from
Calculated from Royalty Pharma’s reported figures.
Based on the most recent quarter.
The official record: Royalty Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Royalty Pharma's price / earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Royalty Pharma's price / earnings?
- Royalty Pharma (RPRX) reported price / earnings of 24.8× in Q1 2026.
- How has Royalty Pharma's price / earnings changed year-over-year?
- Royalty Pharma's price / earnings increased by 101.4% year-over-year, from 12.3× to 24.8×.
- What is the long-term trend for Royalty Pharma's price / earnings?
- Over 2 years (2021 to 2025), Royalty Pharma's price / earnings has grown at a 10.5% compound annual growth rate (CAGR), from 56.2× to 68.5×.
- What does price / earnings mean?
- How many dollars investors pay for each dollar of the company's annual profit.
- How do you interpret price / earnings?
- Lower can mean cheaper — or that the market expects earnings to fall. High multiples embed growth expectations. Meaningless when earnings are negative, so it is suppressed there.
- How does price / earnings compare across companies?
- Compare against the company's own history and sector peers, not across sectors with different growth and risk profiles.